In a Sept. 9 comment letter to the SEC and CFTC, Citadel Securities urged regulators to keep equity-linked event contracts and similar products under SEC oversight.
- Sept. 9 filing: Citadel Securities pushed back on CFTC self-certification
- Core dispute: who regulates products tied to public companies
- KPI contracts: payout linked to company metrics, not just price
- Perpetual derivatives: crypto-style structure, but different risks in equities
The letter, signed by Stephen John Berger, Citadel’s global head of government and regulatory policy, argues that products tied to U.S. public companies belong in the SEC’s surveillance and investor-protection framework. Please provide the HTML content for me to process and that’s not just a turf war for lawyers in expensive shoes. It gets to the heart of whether firms can package stock-linked exposure as something else and slip it through a faster regulatory door.
Citadel’s central complaint is simple: a trading venue should not get to pick its regulator by relabeling an equity-linked product. The firm says the CFTC’s self-certification process lets registered venues declare a product compliant and launch it the next business day, without public comment, while SEC-regulated venues generally face a more formal review process that includes demonstration of compliance, public comment, and affirmative approval before trading can begin.
That speed has a real upside. Faster review can help genuine innovation reach markets without months of bureaucratic delay. But speed is also exactly what bad actors love. If the rules let a venue route a product to the lighter-touch path just by changing the wrapper, that is not financial progress. That is regulatory arbitrage with a fresh coat of paint.
Citadel says that risk is already showing up in key performance indicator contracts, or KPI contracts. These are contracts that pay out based on whether a company hits a specific metric. Think revenue targets, EBITDA thresholds, user-growth milestones, product-launch goals, or any other measurable outcome tied to a public company’s performance.
On paper, that may look like a narrow event-based derivative. In practice, it can resemble a security-linked instrument if the metric reflects the fortunes of a U.S. public company. Citadel argues that some CFTC-registered designated contract markets have self-certified such contracts under CFTC jurisdiction, even though the firm says they should be treated as security-based swaps and therefore fall under SEC authority.
That distinction matters because classification decides the rulebook. SEC oversight brings a different set of disclosure, surveillance, and market-integrity standards than the CFTC framework. If the instrument is really tied to a security, then calling it something else does not magically make the legal issues disappear. Finance has many tricks. Reality is annoyingly stubborn.
Citadel also flags the insider-trading problem. If a contract pays out based on a company metric, someone with access to nonpublic information about that metric could gain an unfair edge. A private update on revenues, subscriptions, or operating performance can become tradable information before the market sees the official numbers. That is exactly the kind of informational asymmetry securities law is built to police.
The letter extends the same concern to perpetual derivatives linked to equities. These are futures-like contracts with no expiry date. Crypto markets popularized the structure, but the format itself is just a derivatives design, not a blockchain invention or a magic exemption from regulation. Citadel Securities and ARK Invest Back LayerZero’s Zero
That matters because perpetuals tied to public-company exposure could move trading outside the SEC’s surveillance and investor-protection framework if they are listed under the wrong regime. A Bitcoin perpetual and an equity-linked perpetual are not the same policy problem. One is a speculative crypto instrument. The other may be a securities-adjacent product dressed up in crypto-style clothing. Same haircut, different face.
Citadel asked both agencies to reaffirm SEC jurisdiction over equity-linked products, stop self-certification from being used to circumvent that jurisdiction, clarify how event contracts and perpetual derivatives should be treated, and commit to timely review of new product filings. The message underneath the lawyerly phrasing is blunt: don’t let venues play regulatory musical chairs until the music stops after launch.
The broader fight is familiar to anyone who has watched U.S. market regulation for more than five minutes. The SEC and CFTC often overlap around new instruments, and that overlap is where firms look for the easiest route. Some products genuinely sit in a gray zone. Others are pushed into one by design because the path is faster, cheaper, or more convenient. That is where the real abuse creeps in.
Citadel’s position will not shock anyone who has seen Wall Street defend its turf while also complaining about competition. The firm has a commercial stake in how these products are classified and where they trade. Still, a vested interest does not make the warning invalid. The concern that venues may try to exploit gaps between the SEC and CFTC frameworks is hardly crazy. It is the sort of thing markets reliably do the moment a loophole appears. Citadel Securities Wants SEC Oversight of Company-
The counterpoint is equally real. Not every novel payout structure is a scam, and not every instrument linked to a company metric belongs in the SEC’s box by default. If regulators cast the net too wide, they could choke off useful experimentation and bury legitimate products under compliance drag. Innovation is not the enemy. Novelty used to dodge supervision is the enemy.
That is the balance regulators have to strike: let useful products launch, but do not hand out loopholes to anyone with enough legal creativity and a printer. The question is not whether new products should exist. The question is whether they should succeed on merit or by gaming the boundary between two regulators that do not always see eye to eye. Citadel Securities Jumps into Crypto Market Boosted by
What does Citadel want the SEC and CFTC to do?
Citadel wants both agencies to make clear that equity-linked products tied to U.S. public companies fall under SEC oversight, and to prevent venues from using the CFTC’s self-certification process to sidestep that framework.
What is CFTC self-certification?
It is a process that can allow a registered venue to list a product quickly after declaring it compliant, rather than waiting for a more formal prior approval process. The CFTC can still review or challenge listings later, but the front-end process is much faster.
Why do KPI contracts raise red flags?
Because their payouts depend on specific company metrics, they can create insider-trading concerns and blur the line between a plain derivative and a security-linked product. That makes classification and surveillance a serious issue.
Why are perpetual derivatives part of this fight?
Perpetuals are common in crypto because they have no expiry date, but an equity-linked perpetual could raise different regulatory and investor-protection concerns. The structure itself is not the issue; the underlying exposure and venue jurisdiction are.
What is the real risk of regulatory arbitrage?
The risk is that a venue chooses the easiest regulator instead of the right one. That can let a product launch before it has been properly tested for market integrity, investor protection, and manipulation risks.
The SEC and CFTC have not publicly responded in the materials available, and no decision date is attached to the joint comment process. For now, the fight is less about fancy product design than a basic question the industry keeps trying to dodge: who gets to police the thing before it starts trading? Citadel Securities, $64B Hedge Fund, Jumps Into Crypto
